Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma.
Yoshimoto M, Kagawa S, Kajioka H, Taniguchi A, Kuroda S, Kikuchi S, Kakiuchi Y, Yagi T, Nogi S, Teraishi F, Shigeyasu K, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Yoshimoto M, et al. Among authors: shigeyasu k. Cancer Lett. 2023 Jul 28;567:216260. doi: 10.1016/j.canlet.2023.216260. Epub 2023 Jun 7. Cancer Lett. 2023. PMID: 37295551
Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.
Shigeyasu K, Kagawa S, Uno F, Nishizaki M, Kishimoto H, Gochi A, Kimura T, Takahata T, Nonaka Y, Ninomiya M, Fujiwara T. Shigeyasu K, et al. Cancer Chemother Pharmacol. 2013 Apr;71(4):937-43. doi: 10.1007/s00280-013-2086-0. Epub 2013 Jan 25. Cancer Chemother Pharmacol. 2013. PMID: 23355040 Clinical Trial.
Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.
Yoshida K, Nagasaka T, Umeda Y, Tanaka T, Kimura K, Taniguchi F, Fuji T, Shigeyasu K, Mori Y, Yanai H, Yagi T, Goel A, Fujiwara T. Yoshida K, et al. Among authors: shigeyasu k. J Cancer Res Clin Oncol. 2016 Jul;142(7):1557-69. doi: 10.1007/s00432-016-2164-x. Epub 2016 Apr 19. J Cancer Res Clin Oncol. 2016. PMID: 27095449 Free PMC article.
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Kagawa S, Muraoka A, Kambara T, Nakayama H, Hamano R, Tanaka N, Noma K, Tanakaya K, Kishimoto H, Shigeyasu K, Kuroda S, Kikuchi S, Kuwada K, Nishizaki M, Shirakawa Y, Fujiwara T. Kagawa S, et al. Among authors: shigeyasu k. Cancer Chemother Pharmacol. 2018 Feb;81(2):387-392. doi: 10.1007/s00280-017-3505-4. Epub 2017 Dec 30. Cancer Chemother Pharmacol. 2018. PMID: 29290024 Clinical Trial.
45 results